Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
NCT ID:
NCT01770366
Eligibility Criteria:
Inclusion Criteria:
* Baystate Medical Center Weight Loss Surgery Program patient scheduled to have weight loss surgery during the recruitment period
* ≥18 years old (weight loss surgery patients younger than 18 years of age represent a unique population, such that an intervention geared towards adult patients would not be appropriate for this younger population)
* English-speaking (research staff are English-speaking only, and we do not have funding available to hire interpreters or bilingual staff)
Exclusion Criteria:
* Anyone judged not medically fit to participate in the study (e.g., severe medical or psychiatric problems), as per the physician's clinical judgment (by direct physician query)
* Patients planning to relocate from the area within the next six months (i.e., during study timeframe)
* Patients currently participating in another research study (due to patient burden and the potential for reduced protocol adherence associated with participation in multiple studies)
* Patients weighing over 420 pounds at baseline (due to the weight range on the wireless weight scale, and to allow for some weight gain between the baseline research visit and the date of surgery)
* Patients who do not have a computer with an internet connection in their home (due to the web-based nature of this virtual support program and the need to have the USB antenna set up in the patient's home to collect weight data)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01770366
Study Brief:
Protocol Section:
NCT01770366